- San Francisco-based MAZAKALI is leveraging its extensive cannabis investment and fundraising advisory experience on the ongoing boom in the industry
- The company foresees the Cannabis complex becoming a trillion-dollar market as society continues to adopt the plant’s use for a large range of medical and industrial purposes
- The inauguration of President Joe Biden is ushering in an era of federal government in which cannabis-friendly officials are being named to key advisory positions in his cabinet and the Democratic Party
- Cannabis is currently legal for medical use in 35 U.S. states and permitted for adult-use in 15 states and the District of Columbia
Market watchers appear to consider liberalization of federal laws regarding cannabis to be a foregone conclusion now that the inauguration of President Joe Biden has taken place. That, in turn, is leading to rosy expectations for cannabis consumption — especially in light of the ongoing march of state-by-state legalization amid a growing acceptance of cannabis for adult-use as well as medicinal purposes.
Cannabis marketplace facilitator MAZAKALI is helping investors seize opportunities to build profitable portfolios in this high growth industry while also assisting companies that are looking to raise capital to fuel their growth. The San Francisco-based capital adviser oversees an online investment marketplace that handles direct investments in a diverse field of vetted opportunities while also serving highly funded clients with personalized portfolio management and an Outsourced Cannabis Investment Officer (“OCIO”) service for asset managers.
Cannabis plays a key role in MAZAKALI’s mission — in 2016 the company began working specifically to help investors place capital and to help companies raise capital. MAZAKALI’s GreenPapers(R) inform investors and operators through insights into deep trends in the cannabis complex, predicting in 2017 that significant federal reform would take place this year with a Democratic victory in the White House.
“We had been following public opinion polls on (cannabis) legalization and noticed a fairly precipitous decline in the opposition to legalization. As an example, from 2007 through (20)17 we saw opposition decline from 60 to 40 percent and support increase even more, from 30 to nearly 60 percent,” MAZAKALI founder and CEO Sumit Mehta said during an interview with Jeremy Neilson, CEO of Assure (https://cnw.fm/FtpZi).
“We then looked at other states-led rights issues that eventually became legal at a federal level and we saw fairly similar trajectories,” Mehta added. “We saw a meaningful uptick in the states that were passing cannabis legalization measures between 2015 and 2017, and knew that the majority of Americans would soon have legal access to this plant with countless stories to share about its medical impact. We expected that this would further bolster the public support that was building, fueled further as media was also becoming far less reticent to cover this increasingly destigmatized topic.”
Cannabis is currently legal for medical use in 35 U.S. states and permitted for adult-use in 15 states (https://cnw.fm/6BTM3). Its use has been adopted by a wide age range of consumers, particularly as older populations turn to cannabidiol (“CBD”) for over-the-counter pain relief and sleep aids (https://cnw.fm/I4Sb6).
In further support for investor confidence, observers have noted that President Biden appears to be stocking his cabinet with several key cannabis-friendly advisers. He has named a strong supporter of cannabis legalization as his nominee to lead the Democratic National Committee (“DNC”) (https://cnw.fm/VuKfR).
“It is likely that Cannabis will prove to be the best performing asset class over the next decade…Hemp will prove to be a major contribution to farmer livelihood as well as industrial and economic output, with the Cannabis complex likely a trillion-dollar market in the making,” MAZAKALI states as part of its advisory profile (https://cnw.fm/IoeT8).
For more information, visit the company’s website at www.MAZAKALI.com.
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire is part of the InvestorBrandNetwork.